Asociación entre síndrome metabólico y enfermedad nodular tiroidea en el Hospital Nacional Edgardo Rebagliati Martins en el año 2014
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Advisors
Piscoya, AlejandroIssue Date
2015-02-02Keywords
Nódulo TiroideoSíndrome X Metabólico
Resistencia a la Insulina
Thyroid Nodule
Metabolic Syndrome X
Insulin Resistance
Metadata
Show full item recordCitation
1. Cornejo Champin RA, Silva Caso WG, Soria Montoya A. Asociación entre síndrome metabólico y enfermedad nodular tiroidea en el Hospital Nacional Edgardo Rebagliati Martins en el año 2014 [Internet]. [Lima, Perú]: Universidad Peruana de Ciencias Aplicadas (UPC); 2015 [cited 2017 Nov 18]. Available from: http://repositorioacademico.upc.edu.pe/upc/handle/10757/621623Abstract
Introduction: Few studies analyses the relation between metabolic syndrome and thyroid nodular disease, subject in which there is a knowledge gap. The object of this study is to determinate the association between metabolic syndrome and thyroid nodular disease in a hospital in Lima, Peru. Materials and methods: A longitudinal, prospective, analytic, observational, case - control study, was performed “Hospital Nacional Edgardo Rebagliati Martins” in Lima- Peru. A total of 182 patients were separated as cases in which at least find a thyroid nodule detected by ultrasonography greater than 3 mm ( n = 91) and controls as patients in whom the presence of the node with the characteristics described was excluded by the same technique (n=91). The level and strength of association was evaluated between the presence of metabolic syndrome and each of its components by itself with the presence of thyroid nodular was evaluated. Results: Bivariate analysis shows significant association between the presence of thyroid nodule and metabolic syndrome with an OR of 2.56 (IC:95% 1.41 to 4.66, p < 0.05). Low levels of HDL and impaired fasting glucose are significant associated with the presence of thyroid nodule, independent of the presence of metabolic syndrome, with an OR of 2.81 (IC:95% 1.54 to 5.12, p<0.05) and 2.05 (IC: 95% 1.10 to 3.78, p<0.05) respectively. The multivariate analysis maintained the association between thyroid nodule and metabolic syndrome with an OR of 2.96 (IC: 95% 1,47 to 5,95 , p<0.05); like was the low levels of HDL with an OR of 2.77 ( IC: 95% 1,44 to 5,3, p<0.05) and with impaired fasting glucose with an OR of 2,23 ( IC 95% 1,14 to 4,34, p<0,05).Conclusions: Metabolic syndrome increases de risk of having thyroid nodule disease. Low HDL levels and impaired fasting glucose were the factors with more association.Type
info:eu-repo/semantics/bachelorThesisRights
info:eu-repo/semantics/openAccessLanguage
spaCollections
The following license files are associated with this item: